Status:
TERMINATED
Commerical DHA Supplementation
Lead Sponsor:
University of New Mexico
Collaborating Sponsors:
National Center for Research Resources (NCRR)
Conditions:
Randomized Clinical Trial
Docosahexaenoic Acid
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare blood levels of women who take commericially available, low dose docosahexaenoic acid (DHA) dietary supplements in pregnancy with women who do not take suppleme...
Detailed Description
The investigators recruited 73 pregnant women in the late third trimester from a low-risk midwifery clinic in compliance with the protocol approved by the investigators institutional review board regu...
Eligibility Criteria
Inclusion
- Pregnant
- 34-36 weeks gestational age
Exclusion
- Maternal medical disease
- Gestational diabetes
- Pre-eclampsia
- Fetal anomalies
- Ingestion of DHA or fish oil dietary supplements during the current pregnancy
Key Trial Info
Start Date :
May 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT05415293
Start Date
May 1 2011
End Date
May 1 2011
Last Update
January 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of New Mexico Hospital
Albuquerque, New Mexico, United States, 87131